Heron Therapeutics (HRTX) Insider Trading & Ownership → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free HRTX Stock Alerts $2.45 -0.10 (-3.92%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Heron Therapeutics (NASDAQ:HRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$3.67 MNumber OfInsiders Selling(Last 12 Months)0 Get HRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Heron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HRTX Insider Buying and Selling by Quarter Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. Heron Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/16/2023Craig A CollardCEOBuy150,000$0.92$138,000.00 11/16/2023Ira DuarteCFOBuy85,000$0.89$75,650.00 11/16/2023William P ForbesEVPBuy50,000$0.94$47,000.00 7/21/2023Adam MorganDirectorBuy2,486,744$1.37$3,406,839.28 (Data available from 1/1/2013 forward) HRTX Insider Trading Activity - Frequently Asked Questions Who is on Heron Therapeutics's Insider Roster? The list of insiders at Heron Therapeutics includes Adam Morgan, Craig A Collard, Ira Duarte, Kimberly Manhard, Waage Christian, and William P Forbes. Learn more on insiders at HRTX. What percentage of Heron Therapeutics stock is owned by insiders? 6.40% of Heron Therapeutics stock is owned by insiders. Learn more on HRTX's insider holdings. Which Heron Therapeutics insiders have been buying company stock? The following insiders have purchased HRTX shares in the last 24 months: Adam Morgan ($3,406,839.28), Craig A Collard ($138,000.00), Ira Duarte ($75,650.00), and William P Forbes ($47,000.00). How much insider buying is happening at Heron Therapeutics? Insiders have purchased a total of 2,771,744 HRTX shares in the last 24 months for a total of $3,667,489.28 bought. Which Heron Therapeutics insiders have been selling company stock? The following insider sold HRTX shares in the last 24 months: Kimberly Manhard ($7,159.04). How much insider selling is happening at Heron Therapeutics? Insiders have sold a total of 1,504 Heron Therapeutics shares in the last 24 months for a total of $7,159.04 sold. More Insider Trading Tools from MarketBeat Related Companies: MRSN Insider Ownership ORGO Insider Ownership BMEA Insider Ownership ESPR Insider Ownership CRBP Insider Ownership RVNC Insider Ownership PEPG Insider Ownership ANNX Insider Ownership NKTX Insider Ownership ANRO Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:HRTX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
